跳至主要内容
临床试验/NCT02597985
NCT02597985已完成不适用

Prehabilitation to Improve Functional and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: TAVR-FRAILTY Trial

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2015年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
13
试验地点
1
主要终点
Change in Score on short physical performance battery (SPPB) test

研究概览

简要总结

Transcatheter aortic valve replacement (TAVR) is a treatment alternative among high-risk elderly with aortic stenosis, however, mortality remains high. Fifty percent of patients undergoing TAVR exhibit frailty, a syndrome associated with poor survival. It is unknown whether interventions to improve frailty before TAVR (prehabilitation) will improve outcomes after TAVR. This study plans to evaluate whether simple cardiac exercise interventions to improve physical performance before TAVR improves outcomes after TAVR.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Eligibility for TAVR
  • •Able to exercise
  • •Able to come for follow-up visits
  • •Able to give informed consent

排除标准

  • •New York Heart Association (NYHA) Class III/IV congestive heart failure (CHF)
  • •Presyncope or syncope as presentation
  • •Acute coronary syndrome
  • •Unable to exercise
  • •Sustained ventricular arrhythmia
  • •Stroke with neurological deficit
  • •Advanced Parkinson's
  • •Participated in an exercise program

研究组 & 干预措施

Prehabilitation

Active Comparator

Will receive 4 weeks of supervised exercised prescription before they undergo TAVR and will monitor and record, improvement if any, in the short-term physical performance battery score

干预措施: Prehabilitation (Other)

Usual care

Placebo Comparator

Will receive usual care

干预措施: Usual Care (Other)

结局指标

主要结局

Change in Score on short physical performance battery (SPPB) test

时间窗: Baseline, approximately 1 year

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mandeep Singh

Professor of Medicine

Mayo Clinic

研究点 (1)

Loading locations...

相似试验